13F filing recap · Q2 2023

What did Dodge & Cox buy in Q2 2023?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Dodge & Cox account, including accounts that belong to no fund below.

Stock value

$149.86B

Positions

191

Estimated turnover

6.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

KMXCarmax, Inc.$213.4Kreported value+2.5K shares

Increased positions

CIThe Cigna Group$3.37Breported value+563.3K shares+4.9%UBSUbs Group AG$3.14Breported value+226.9K shares+0.1%METMetlife, Inc.$3.06Breported value+83.9K shares+0.2%REGNRegeneron Pharmaceuticals, Inc.$1.72Breported value+9.7K shares

Reduced positions

OXYOccidental Petroleum Corporation$5.37Breported value-852.4K shares-0.9%WFCWells Fargo & Company/mn$5.13Breported value-242.5K shares-0.2%GOOGAlphabet Inc.$4.87Breported value-3.24M shares-7.5%FISVFiserv Inc$4.50Breported value-591.8K shares

Exited positions

NVDANvidia Corp$33.00Mprior reported value-118.8K shares-100.0%SNOWSnowflake Inc.$26.19Mprior reported value-169.8K shares-100.0%AIC3.ai, Inc.$6.04Mprior reported value-180.0K shares-100.0%HZNPHorizon Therapeutics Public Limited Company$2.45Mprior reported value-22.5K shares